Centene’s biggest stock drop in years—what’s behind the plunge?
Centene Corporation’s shares experienced their steepest decline in four years, plunging by 7.7% after news of a renewed contract for its subsidiary, Iowa Total Care, ... Read More
PACS Group stock plunges 9% after massive 14 million share offering stuns investors
PACS Group, Inc., a prominent player in the post-acute healthcare sector, has seen its shares nosedive by nearly 9% to $35.98 following the announcement of ... Read More
Illumina’s stunning victory against EU regulators changes the game for mergers
In a landmark decision that could redefine the boundaries of European merger control, the Court of Justice of the European Union (CJEU) ruled in favor ... Read More
Telesis Bio faces major reshuffle as CEO Eric Esser named chair amid board resignations
Telesis Bio Inc., a company specialising in laboratory analytical instruments, has named its CEO, Eric Esser, as the new chair of the board following the ... Read More
Urgent alert as bluetongue virus spreads in Norfolk and Suffolk—farmers must act now!
A bluetongue virus outbreak has prompted the UK Chief Veterinary Officer to declare a restricted zone across Norfolk and Suffolk, as cases of Bluetongue virus ... Read More
RebrAIn expands capabilities with second FDA 510(k) clearance for OptimMRI software
RebrAIn, a France-based precision neurosurgery platform, has achieved a significant milestone with its second FDA 510(k) clearance for the OptimMRI software, marking a notable advancement ... Read More
Breakthrough study reveals Delcath Systems’ therapy doubles survival for uveal melanoma patients
Delcath Systems, Inc. (Nasdaq: DCTH), a pioneering company in interventional oncology, has announced promising results from a recent independent study evaluating its liver-directed therapy for ... Read More
Philip Morris International injects $232m into Kentucky plant expansion, promising 450 new jobs
Philip Morris International Inc. (PMI) (NYSE: PM) is making a significant investment in its U.S. operations, committing $232 million to expand its Owensboro, Kentucky, manufacturing ... Read More
Telix Pharmaceuticals submits NDA for Pixclara to advance brain cancer imaging
Telix Pharmaceuticals Limited (ASX: TLX) has taken a significant step in the realm of neuro-oncology by submitting a New Drug Application (NDA) to the U.S. ... Read More
Illumina secures FDA approval for comprehensive cancer test and two companion diagnostics
Illumina, Inc. (NASDAQ: ILMN), a global leader in the field of DNA sequencing and array-based technologies, has secured crucial approval from the Food and Drug ... Read More